These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22840785)

  • 1. Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature.
    Rabinowits G; Haddad RI
    Oral Oncol; 2012 Nov; 48(11):1085-9. PubMed ID: 22840785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to EGFR inhibitors in head and neck cancer.
    Cooper JB; Cohen EE
    Head Neck; 2009 Aug; 31(8):1086-94. PubMed ID: 19378324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR codon 497 polymorphism - implications for receptor sensitivity to inhibitors in HNSCC cell lines.
    Krohn V; Wiegand S; Werner JA; Mandic R
    Anticancer Res; 2011 Jan; 31(1):59-65. PubMed ID: 21273581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor biology in head and neck cancer.
    Kalyankrishna S; Grandis JR
    J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.
    Sundvall M; Karrila A; Nordberg J; Grénman R; Elenius K
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):185-201. PubMed ID: 20415599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas.
    Martinez-Useros J; Garcia-Foncillas J
    Oral Oncol; 2015 May; 51(5):423-30. PubMed ID: 25753560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
    Le Tourneau C; Siu LL
    Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells.
    Saki M; Toulany M; Rodemann HP
    Radiother Oncol; 2013 Sep; 108(3):473-8. PubMed ID: 23891090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).
    Price KA; Cohen EE
    Oral Oncol; 2015 May; 51(5):399-408. PubMed ID: 25725588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines.
    Kondo N; Tsukuda M; Sakakibara A; Takahashi H; Hyakusoku H; Komatsu M; Niho T; Nakazaki K; Toth G
    Int J Oncol; 2012 Jun; 40(6):1805-12. PubMed ID: 22344385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.
    Burtness B; Bauman JE; Galloway T
    Lancet Oncol; 2013 Jul; 14(8):e302-9. PubMed ID: 23816296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.
    Jedlinski A; Ansell A; Johansson AC; Roberg K
    J Oral Pathol Med; 2013 Jan; 42(1):26-36. PubMed ID: 22643066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapies in squamous cell carcinoma of the head and neck.
    Gold KA; Lee HY; Kim ES
    Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.
    Boeckx C; Op de Beeck K; Wouters A; Deschoolmeester V; Limame R; Zwaenepoel K; Specenier P; Pauwels P; Vermorken JB; Peeters M; Van Camp G; Baay M; Lardon F
    Cancer Lett; 2014 Nov; 354(2):365-77. PubMed ID: 25192874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma.
    Gyanchandani R; Sano D; Ortega Alves MV; Klein JD; Knapick BA; Oh S; Myers JN; Kim S
    Oral Oncol; 2013 Aug; 49(8):761-70. PubMed ID: 23623402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
    Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U
    Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor alpha stimulation of mucosal tissue cultures from head and neck squamous cell carcinoma patients increases chemoresistance to cisplatin.
    Baumeister P; Reiter M; Schwenk-Zieger S; Harréus U
    Chemotherapy; 2010; 56(4):268-74. PubMed ID: 20693797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.